| ²é¿´: 369 | »Ø¸´: 0 | |||
¹ú¼Ê¿ÆÑ§±à¼
|
[½»Á÷]
ÍòÊ¿ªÍ·ÄÑ£¬¾ÍÒòΪժҪûдºÃ£¬Ö±½Ó±»¾Ü£¿
|
|
µ±Ä㻹ÊÇСѧÉúµÄʱºò£¬ÓïÎÄÀÏʦ¾Í¶úÌáÃæÃü£¬×÷ÎÄ¿ªÍ·ºÜÖØÒª£¬Ð´Ò»¸öºÃµÄ¿ªÍ·¾Í³É¹¦ÁËÒ»°ë¡£ÎÒÒ»Ö±ÒÔΪÕâÊÇÓ¦ÊÔ½ÌÓý½×¶Î²Å»áÓеĶ«Î÷£¬À뿪ÁËÓ¦ÊÔ×÷ÎÄ£¬ÎҾͿÉÒÔÔÚ×Ô¼ºÎÄ×ֵĺ£ÑóÀïËÁÒâ°¿Ï裬ÈÃËùÓп´µ½ÎÒÎÄÕµÄÈ˸ÐÊÜÎÒÌìÂíÐпյÄ˼ά£¬ÈÃËûÃǸÐÊÜһϣ¬Ê²Ã´½Ð×öÕæÕýµÄÎÄѧ¹¦µ×¡£ È»¶øµ±ÎÒ¶Áµ½ÁËÑо¿Éú²Å·¢ÏÖ£¬ÎÄѧ¹¦µ×ÕâËĸö×Ö£¬ÊÇÎҵȿÆÑÐÍô²»ÅäÓµÓеġ£ÂÛÎÄÊÇ·ñ¿ÉÒÔ·¢¸øºÏÊʵÄÅãÉóר¼Ò£¬½ø¶ø³É¹¦·¢±í£¬ÕâÆäÖÐÕªÒªµÄ×÷ÓÃÖÁ¹ØÖØÒª¡£ÑªÁÜÁܵÄÊÂʵ°ÚÔÚÑÛǰ£¬¸ô±ÚʵÑéÊÒʦÐÖ»¨·Ñ´ó°ëÄêÐÄѪдµÄÂÛÎÄ£¬Æäµ¼Ê¦Ò²¾õµÃÎÄÕºÍÑо¿ÏîÄ¿¿ÉȦ¿Éµã£¬µ«»¹Ã»ÓÐËÍÉó¾Í±»¾ÜÁË£¬×îºó·¢ÏÖ¾ÍÊÇÒòΪժҪÖжÔÑо¿Ä¿µÄºÍÖØÒªÍ»ÆÆÐ´µÄ²»¹»Çå³þ¡£ ¸üÓÐÉõÕߣ¬°ÑÕªÒªºÍǰÑÔ»ìΪһ̸£¬¶àÊýÆÚ¿¯µÄÕªÒªÒªÇó250×ÖÒÔÄÚ£¬×÷ÕßÐëÒÔ¾«Á¶µÄÓïÑÔ²ûÃ÷ÎÄÕµı³¾°£¬ÖØÒª¿ÆÑÐÍ»ÆÆ£¬ÒÔÑо¿ÒâÒå¡£¶øÇ°ÑÔ¸ü²àÖØÓÚ±³¾°½éÉÜ£¬Ìá³öÎÊÌâºÍ×ܽáÁìÓòÄÚÑо¿½øÕ¹¡£ Ò»¸öÐèÒª¾«Á¶£¬Ò»¸öÐèÒªÏ꾡£¬¿ÉνÌì²îµØ±ð¡£ DZÔÚµÄÉó¸åÈËͨ³£ÔÚÊÕµ½Í¬ÐÐÆÀÉóÑûÇëʱ£¬Ö»»á¿´µ½ÎÄÕµıêÌâºÍÕªÒª¡£Ö»ÓÐÔÚ½ÓÊÜÉó¸åÑûÇëºó£¬ËûÃDzÅÄÜ»ñµÃÍêÕûµÄÂÛÎÄÈ«ÎÄºÍÆäËûÖ§³Ö²ÄÁÏ¡£Òò´Ë£¬ÄãµÄÎÄÕÂÕªÒª¶ÔÓÚÎüÒýºÍÈ·±£ÕýÈ·µÄÉó¸åÈ˽øÐÐÉó¸åÖÁ¹ØÖØÒª¡£ ÔÚÕâÆªÎÄÕÂÖУ¬¹ú¼Ê¿ÆÑ§±à¼-ISE½«ºÍ´ó¼ÒÒ»ÆðÌÖÂÛ£ºÈçºÎͨ¹ýÓÅÐãµÄÕªÒª¸øÉó¸åÈËÁôÏÂÁ¼ºÃµÄµÚÒ»Ó¡Ïó£¬È·±£ÄãµÄÂÛÎÄÄÜ·¢¸ø×îºÏÊʵÄͬÐÐÆÀÉóר¼Ò¡£ ÕªÒª ½á¹¹Á¼ºÃµÄÕªÒª£¨Í¨³£Îª200-300¸öµ¥´Ê£©Í¨³£×ñÑIMRD / Cģʽ (Introdcution, Method, Result, Discussion/Conclusion£©½á¹¹£¬¶ÁÆðÀ´ÀàËÆÓÚһƪËõС°æµÄÂÛÎÄ¡£ ¿´ÆðÀ´ÈÝÒ××öÆðÀ´ÄÑ£¬Ð´Ò»¸öºÃÕªÒªÊÇÒ»¼þºÜÁîÈËÍ·ÌÛµÄÊ£¬ÉõÖÁÓÐֻƾ½èдժҪÕâ¼þʱ¾Éí¾ÍÊÇ¿ÉÒÔ·¢ÆªÂÛÎĵģº ÔÚ¹¹½¨ÕªÒªÊ±£¬Òª¿¼ÂÇÒÔϼ¸µã£º •±£³Ö¼òÃ÷¶óÒªµÄ½éÉÜ¡£ •ÔÚÒýÑÔÖвûÊöÕâÏîÑо¿µÄÀíÓÉ¡£ •Ã÷ȷ˵Ã÷Ñо¿¼ÙÉè/Ä¿±ê¡£ •±£³Ö·½·¨¼ò½à£¬Îª½á¹ûºÍ½áÂÛ½ÚÊ¡¿Õ¼ä¡£ •½á¹ûÓ¦¹¹³ÉÕªÒªµÄÖ÷Ì岿·Ö¡£ •ÓôÊÒª¼æ¹ËЧ¹ûµÄ·½ÏòºÍ´óС£¨ÀýÈç e.g., lower, fewer, reduced; greater, more, increased £©ºÍÔËÓÃÊý×Ö¡£ ÀýÈ磬²îµÄÌâÄ¿£º¡°Daily pain scores differed significantly between gabapentin-treated patients and placebo-treated patients¡± ºÃµÄÌâÄ¿£º¡°Daily pain scores were significantly lower in gabapentin-treated patients compared to placebo-treated patients (2.8 vs. 5.1, p<0.001)¡± •°üÀ¨ÎÄÕÂËùÓеķ¢ÏÖ¡£½á¹ûÓ¦¸ÃÇå³þµØ·´Ó³ÍêÕûµÄ±¨¸æ£¬¼´²»½öÒªÌá³ö¾ßÓÐͳ¼ÆÒâÒåµÄ½á¹û£¬»¹ÒªÅųýÄÇЩ²»¾ßÓÐͳ¼ÆÒâÒåµÄ½á¹û¡£ •°üÀ¨ÈκÎì¶Ü»ò¸ºÃæµÄµ÷²é½á¹û¡£ •Ìá¼°Ñо¿µÄËùÓоÖÏÞÐÔ¡£ •²ûÊöÓë¼ÙÉè/Ä¿±êÏà¹ØµÄÖ÷Òª½áÂÛ¡£ ÈçºÎÍÆ¼öºÏÊʵÄÉó¸åÈË ´ó¶àÊýÆÚ¿¯ÏÖÔÚÒªÇó×÷ÕßÍÆ¼öÁ½µ½ÈýÃûDZÔÚµÄÉó¸åÈË¡£Èç¹ûÄãµÄ½¨ÒéÓëÆÚ¿¯±à¼µÄÒâ¼ûÒ»Ö£¬ÄãµÄ½¨ÒéºÜ¿ÉÄÜ»áµÃµ½²ÉÄÉ¡£¶Ô×÷ÕßÀ´Ëµ£¬Ç§Íò²»ÒªÐ¡¿´ÁËÍÆ¼öÉó¸åÈ˵ľٶ¯£¬ÓÐʱºò£¬Ëû¶ÔÓÚÄãÎÄÕÂ×îÖÕ×ßÏò»ò¶ÔÄã¸öÈ˵ÄѧÊõÓ°Ïì¿ÉÄÜÊǾ޴óµÄ¡£Òò´Ë£¬ÖµµÃ»¨Ê±¼ä×ÐϸѡÔñDZÔÚµÄÉó¸åÈË£¬ÈÃ×Ô¼º´¦Óڱ༵ĽǶȿ¼ÂÇÎÊÌâ¡£ ͨ³£ÈÏΪ£¬²©Ê¿ºóÑо¿ÈËÔ±ÌṩµÄͬÐÐÆÀÉ󱨸æ×îÎªÈ«Ãæ[3]¡£Òò´Ë£¬ÆÚ¿¯±à¼Í¨³£µÄÄ¿±ê»áÈ·±£ÖÁÉÙÓÐÒ»ÃûÏà¹ØÑо¿ÈËÔ±µ£ÈÎÉó¸åÈË¡£Ñ°ÕÒÄãËùÔÚµØÇøÕ¸Â¶Í·½ÇµÄÑо¿ÈËÔ±£¬ÌرðÊÇÄÇЩ×î½ü·¢±í¹ýÂÛÎĵÄ×÷Õß¡£ Ïò±à¼Ìṩһ¸öÇåÎúµÄÃèÊö£¬²ûÊöÿ¸öÄãÍÆ¼öµÄÉó¸åÈ˶¼ºÏÊʵÄÔÒò¡£Èç¹ûÄãÄÜÃ÷È·µØÖ¤Ã÷ËûÃǵĺÏÀíÐÔ£¬ÄãµÄÑ¡Ôñ¸üÓпÉÄܱ»²ÉÄÉ¡£ ×ܽ᣺ ÓÃÉÙÁ¿µÄÓôÊÇ¡µ±µÄ³ÂÊö³öÂÛÎĵÄÕªÒª£¬Í»ÏÔ³öÁÁµã£¬½á¹ûÏêʵ¡¢Í¬Ê±Äܹ»¸ü¼ÓÎüÒý¶ÁÕßÔĶÁ£¬Ôö¼Ó±à¼ºÍÉó¸åÈ˵ĺøУ¬²¢ÍƼö¼¸ÃûÉó¸åÈË£¬²ûÊöÀíÓÉ£¬×öµ½Õ⼸µã²ÅÊÇÎüÒýºÏÊÊÉó¸åÈ˵Ĺؼü¡£ |
» ²ÂÄãϲ»¶
323·Ö£¨¼ÆËã»úÊÓ¾õºÍ´óÄ£ÐÍÏîÄ¿£©ÄÜÖ±½ÓÉÏÊÖ
ÒѾÓÐ3È˻ظ´
¸´ÊÔµ÷¼Á
ÒѾÓÐ3È˻ظ´
311·Ö 22408 Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
320·ÖÈ˹¤ÖÇÄܵ÷¼Á
ÒѾÓÐ7È˻ظ´
Ò»Ö¾Ô¸Ö£´ó0705Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
0703»¯Ñ§
ÒѾÓÐ10È˻ظ´
301Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
306·Ö²ÄÁÏÓ뻯¹¤Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
²ÄÁϵ÷¼Á
ÒѾÓÐ11È˻ظ´
324Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´















»Ø¸´´ËÂ¥
120